How should elevated ferritin be evaluated and managed?

Evaluation and Management of Elevated Ferritin

Measure transferrin saturation (TS) alongside ferritin to distinguish true iron overload from inflammatory hyperferritinemia—if TS ≥45%, proceed with HFE genetic testing for hereditary hemochromatosis; if TS <45%, the elevated ferritin reflects inflammation, metabolic syndrome, or other non-iron causes and requires treatment of the underlying condition rather than phlebotomy. 1

Initial Diagnostic Algorithm

Step 1: Obtain Transferrin Saturation

• Always measure TS simultaneously with ferritin to properly assess iron status—ferritin alone cannot distinguish iron overload from inflammation 1, 2
• TS ≥45% indicates probable iron overload and warrants HFE genetic testing for C282Y and H63D mutations 1
• TS <45% indicates inflammatory hyperferritinemia rather than true iron overload, accounting for over 90% of hyperferritinemia cases in outpatients 1, 3

Step 2: Interpret the Pattern

When TS ≥45%:

• Proceed immediately to HFE genetic testing 1
• If C282Y homozygous with ferritin <1000 μg/L and normal liver enzymes, initiate prophylactic phlebotomy without liver biopsy 4
• If ferritin >1000 μg/L or abnormal liver enzymes, consider liver biopsy to assess fibrosis before treatment 4

When TS <45%:

• Focus diagnostic workup on non-iron causes 1:
  • Inflammatory conditions (most common): infection, autoimmune disease, chronic inflammation 1, 3
  • Metabolic syndrome/NAFLD: present in obese patients with insulin resistance 1, 2
  • Malignancy: accounts for 24% of ferritin >1000 μg/L in adults 5
  • Alcohol consumption: common cause of secondary hyperferritinemia 3
  • Liver disease: hepatitis C, alcoholic liver disease, NAFLD 4

Management Based on Etiology

For Confirmed Hereditary Hemochromatosis (TS ≥45% + HFE mutations)

Initial Depletion Phase:

• Remove 500 mL blood weekly or biweekly until ferritin reaches 50-100 μg/L 4, 6
• Each unit removes approximately 200-250 mg iron; depletion may require 2-3 years for severe overload (>30g total body iron) 4, 6
• Check hemoglobin before every phlebotomy—discontinue if hemoglobin falls below 11 g/dL, reduce frequency if 11-12 g/dL 6
• Do not allow hemoglobin/hematocrit to decline by more than 20% from baseline 4, 6
• Monitor ferritin every 10-12 phlebotomies (approximately every 3 months) during depletion 4
• When ferritin drops below 200 μg/L, increase monitoring to every 1-2 sessions to prevent overshooting the target 6

Maintenance Phase:

• Continue phlebotomy every 1-4 months to maintain ferritin 50-100 μg/L 4, 6
• Untreated patients typically reaccumulate approximately 100 μg/L ferritin per year 6
• Check ferritin every 6 months during maintenance to adjust phlebotomy frequency 6
• Not all patients reaccumulate iron; some may require only 1-2 units per year 4

Critical Safety Considerations:

• Avoid vitamin C supplements during treatment—vitamin C accelerates iron mobilization to potentially dangerous levels 4, 6
• Patients with cardiomyopathy or arrhythmias require slower phlebotomy schedules due to risk of sudden cardiac death from rapid iron mobilization 4, 6
• Avoid raw shellfish due to Vibrio vulnificus infection risk in iron-overloaded patients 4, 6
• Dietary iron restriction is unnecessary—a single phlebotomy removes 200-250 mg iron versus only 2-4 mg/day absorbed from diet 4, 6

For Inflammatory Hyperferritinemia (TS <45%)

Management Strategy:

• Treat the underlying condition, not the ferritin number itself 1, 2
• Phlebotomy is contraindicated and potentially harmful in inflammatory hyperferritinemia 1

Specific Interventions by Cause:

• Metabolic syndrome/obesity: weight loss through caloric restriction and increased physical activity addresses the root inflammatory cause 2
• NAFLD: lifestyle modification with weight loss improves both hepatic steatosis and ferritin elevation 2
• Diabetes: optimize glycemic control, as diabetes independently elevates ferritin even after controlling for BMI 2
• Chronic hepatitis C: phlebotomy reduces ALT but has no effect on viral clearance and is not recommended for mild secondary iron overload 4
• Alcoholic liver disease: no published evidence supports phlebotomy benefit 4

Special Populations

Ferritin >1000 μg/L

• Refer to gastroenterology, hematology, or iron overload specialist if ferritin >1000 μg/L or cause remains unclear after initial workup 3
• In this range, malignancy accounts for 24% of cases in adults, iron overload syndromes 22%, and infection/inflammation remain common 5

Extremely Elevated Ferritin (>10,000 μg/L)

• Hematologic malignancy is the most common cause in adults (26%), while hemophagocytic lymphohistiocytosis (HLH) accounts for only 14% 7
• In children, HLH is more common (49% of cases) but still not the majority diagnosis 7
• Adult-onset Still's disease, systemic juvenile idiopathic arthritis, and HLH average ferritin 14,242 μg/L but represent only 1% of hyperferritinemia cases 5

Chronic Inflammatory Conditions (CKD, CHF, IBD)

• Standard ferritin threshold <30 μg/L does not apply due to inflammation 8
• Use ferritin <100 μg/L or TS <20% to diagnose iron deficiency 8
• If ferritin 100-300 μg/L, require TS <20% to confirm iron deficiency 8
• In CKD with obesity, ferritin 500-1200 μg/L with TS <25% may represent functional iron deficiency responsive to IV iron 2

Common Pitfalls to Avoid

• Never initiate phlebotomy based on elevated ferritin alone—TS <45% indicates inflammation, not iron overload, and phlebotomy is inappropriate 1, 2
• Continuing phlebotomy when ferritin falls below 50 μg/L triggers compensatory dietary iron absorption and symptomatic iron deficiency 6
• Failing to check hemoglobin before each session can lead to severe anemia—the 11 g/dL (stop) and 12 g/dL (reduce) thresholds provide clear decision points 6
• Assuming extremely high ferritin indicates HLH or Still's disease—malignancy and infection are far more common causes even at ferritin >10,000 μg/L 5, 7
• Treating ferritin as the target in inflammatory conditions—address the underlying metabolic or inflammatory disorder instead 1, 2

Expected Outcomes with Appropriate Treatment

For hereditary hemochromatosis treated before cirrhosis develops:

• Improved survival equivalent to general population 4
• Elimination of HCC risk if iron removal achieved before cirrhosis 4
• Improved fatigue, malaise, abdominal pain, and skin pigmentation 4
• Improved cardiac function and diabetic control 4
• Reversal of hepatic fibrosis in approximately 30% of cases 4

For established cirrhosis:

• Advanced cirrhosis does not reverse with phlebotomy 4
• HCC risk persists despite adequate iron removal, requiring ongoing surveillance 4
• HCC accounts for 30% of HH-related deaths, cirrhosis complications another 20% 4